Poland - Pharmaceutical products

For more information and to make a bid you will need to go to the third party website.

Details

Provided by Open Opps
Opportunity closing date
25 February 2022
Opportunity publication date
25 January 2022
Category
33600000: Ph
Value of contract
to be confirmed
Your guide to exporting
Report opportunity

Description

The subject of the present public procurement procedure is successive supplies of drugs and pharmaceuticals to the Hospital Pharmacy for the needs of "Pro-Medica" in Ełk, of which the detailed description and quantities are specified in Appendix No. 3 to the SWZ - i.e. the assortment and price form.
Drugs I Drugs II Drugs III Drugs IV Drugs V Drugs VI Drugs VII Drugs VIII Drugs IX Drugs X Drugs XI Drugs XII MEDICINAL ABSORBED BLOCK HEPARINES XIII MIDAZOLAM METHYLTHIONINIUM CHLORIDE METAMIZOLE SODIUM ALTEPLASE METHYLTHIONINIUM CHLORIDE METAMIZOLE SODIUM ALTEPLASE PARACETAMOL PARACETAMOL NARKOTICS INHALED ANESTHETICS AND INHALED ANESTHETICS II ALBUMIN ALBUMIN/IMMUNOGLOBULIN IMMUNOGLOBULIN I IMMUNOGLOBULIN II IMMUNOGLOBULIN III PORACTANT ALFA OMEPRAZOLE / PANTOPRAZOLE DOBUTAMINE CONTRAST AGENTS ATOSIBAN CITICOLINUM INSULIN I INSULIN II INFLUENZA VACCINE HUMAN PAPILLOMA VIRUS VACCINE ANTIBIOTICS I ANTIBIOTICS II ANTIBIOTICS V CIPROFLOXACIN LINEZOLID AMPHOTERICIN CYTOSTATIC CHEMOTHERAPY DRUGS OMALIZUMABUM MEPOLIZUMABUM PALIVIZUMABUM PARENTERAL NUTRITION I ( NEONATES) PARENTERAL NUTRITION II PARENTERAL NUTRITION III PARENTERAL NUTRITION IV PARENTERAL NUTRITION V PARENTERAL NUTRITION V PARENTERAL NUTRITION ENTERAL NUTRITION I ENTERAL NUTRITION II ENTERAL NUTRITION III ENTERAL NUTRITION MILK INFUSION LIQUIDS I INFUSION LIQUIDS II INFUSION LIQUIDS III INFUSION LIQUIDS IV INFUSION LIQUIDS V INFUSION LIQUIDS VI HEMOFILTRATION FLUIDS PRESCRIPTION DRUGS IMPORTATION TARGET

Opportunity closing date
25 February 2022
Value of contract
to be confirmed

About the buyer

Address
"Pro-Medica" w Ełku Sp. z o.o. ul.Baranki 24 Ełk 19-300 Poland
Contact
przetargi@szpital.elk.pl

The deadline to apply for this opportunity has passed.
Visit the opportunities page to find another.

Is there anything wrong with this page?